Marshall Islands vs Micronesia, Federated States of: The number of people with susceptibility test result for rifampicin
Marshall Islands
31
in 2021
Micronesia, Federated States of
27
in 2021
Marshall Islands rank
127th
Micronesia, Federated States of rank
129th
The number of people with susceptibility test result for rifampicin over time
- Marshall Islands
- Micronesia, Federated States of
How they compare
Marshall Islands currently reports 31 against 27 in Micronesia, Federated States of, a difference of 4.
That makes Marshall Islands's figure about 1.1 times Micronesia, Federated States of's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Marshall Islands ahead.
Marshall Islands ranks 127th and Micronesia, Federated States of ranks 129th of 155 countries.
Across the 2 decades both report, Marshall Islands averaged higher in 1 and Micronesia, Federated States of in 1.
Head to head by decade
| Decade | Marshall Islands | Micronesia, Federated States of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 54 | 32 | 22 | Marshall Islands |
| 2020s | 25.5 | 28 | 2.5 | Micronesia, Federated States of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Marshall Islands or Micronesia, Federated States of?
- Marshall Islands, at 31 against 27 in Micronesia, Federated States of as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Marshall Islands and Micronesia, Federated States of?
- 4, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Micronesia, Federated States of?
- 5 years are reported by both, from 2017 to 2021.
- How do Marshall Islands and Micronesia, Federated States of rank globally for the number of people with susceptibility test result for rifampicin?
- Marshall Islands ranks 127th and Micronesia, Federated States of ranks 129th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.